SMAD4 and carcinoma: Furthermore, PDAC cells with intact SMAD4 are more sensitive to TGF-β1 inhibitor treatment to reduce cell migration, whereas PDAC cells lacking SMAD4 showed decreased cell motility in response to EGFR inhibitor treatment in PDAC carcinoma tissue16,17.